Showing results (1371-1380 of 2,818) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|June 12, 2023
One Size Fits All Versus Individualized Medicine in Type 1 Diabetes ManagementL Kurt Midyett
Diabetes Technology & Therapeutics|April 17, 2023
A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72Roy W Beck, Lauren G Kanapka, Marc D Breton, et al.
Diabetes Technology & Therapeutics|October 30, 2023
12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes PatientsLaura Nigi, Gabriele Iraci Sareri, Dorica Cataldo, et al.
Diabetes Technology & Therapeutics|May 13, 2022
Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4Jordan E Pinsker, Eyal Dassau, Sunil Deshpande, et al.
Diabetes Technology & Therapeutics|December 28, 2021
Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in GreeceVaia Lambadiari, Asli Zeynep Ozdemir Saltik, Simona de Portu, et al.
Diabetes Technology & Therapeutics|July 10, 2007
The AIR inhaled insulin system: system components and pharmacokinetic/glucodynamic dataDouglas B Muchmore, Bernard Silverman, Amparo De La Peña, et al.
Diabetes Technology & Therapeutics|September 15, 2021
Continuous Glucose Monitoring Sensor Glucose Levels and Insulin Pump Infusion Set Wear-Time During Treatment with Fast-Acting Insulin Aspart: A Post Hoc Analysis of Onset 5Anders Gorst-Rasmussen, Jeppe Sturis, Magnus Ekelund
Diabetes Technology & Therapeutics|April 11, 2014
Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trialDavid A Cavan, Ralph Ziegler, Iain Cranston, et al.
Diabetes Technology & Therapeutics|January 25, 2017
Administration of Biosimilar Insulin Analogs: Role of DevicesLutz Heinemann, Ingo Fritz, Hootan Khatami, et al.
Diabetes Technology & Therapeutics|May 29, 2026
Increased Glycation Ratio and Risk of Complications in Latent Autoimmune Diabetes in Adults Compared With Type 1 Diabetes Onset before 30 Years: A Cohort StudySandra Herranz-Antolín, Fernando Gómez-Peralta, Xu Yongjin, et al.
Pageof 282